Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs IV Palonosetron for CINV in HEC
NCT01363479Phase 3Completed
- Sponsor
- Helsinn
- Start
- Jul 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of palonosetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by Helsinn. Started Jul 2011; status: completed.
02
Drugs
palonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT01363479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01363479.